These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 36422669)

  • 1. Multidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohort.
    Schild AK; Goereci Y; Scharfenberg D; Klein K; Lülling J; Meiberth D; Schweitzer F; Stürmer S; Zeyen P; Sahin D; Fink GR; Jessen F; Franke C; Onur OA; Kessler J; Warnke C; Maier F
    J Neurol; 2023 Mar; 270(3):1215-1223. PubMed ID: 36422669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six-month follow-up of multidomain cognitive impairment in non-hospitalized individuals with post-COVID-19 syndrome.
    Schild AK; Scharfenberg D; Regorius A; Klein K; Kirchner L; Yasemin G; Lülling J; Meiberth D; Schweitzer F; Fink GR; Jessen F; Franke C; Onur OA; Jost ST; Warnke C; Maier F
    Eur Arch Psychiatry Clin Neurosci; 2024 Jul; ():. PubMed ID: 39048833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive and psychiatric symptom trajectories 2-3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK.
    Taquet M; Skorniewska Z; De Deyn T; Hampshire A; Trender WR; Hellyer PJ; Chalmers JD; Ho LP; Horsley A; Marks M; Poinasamy K; Raman B; Leavy OC; Richardson M; Elneima O; McAuley HJC; Shikotra A; Singapuri A; Sereno M; Saunders RM; Harris VC; Rogers N; Houchen-Wolloff L; Greening NJ; Mansoori P; Harrison EM; Docherty AB; Lone NI; Quint J; Brightling CE; Wain LV; Evans RA; Geddes JR; Harrison PJ;
    Lancet Psychiatry; 2024 Sep; 11(9):696-708. PubMed ID: 39096931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiles of objective and subjective cognitive function in Post-COVID Syndrome, COVID-19 recovered, and COVID-19 naïve individuals.
    Bland AR; Barraclough M; Trender WR; Mehta MA; Hellyer PJ; Hampshire A; Penner IK; Elliott R; Harenwall S
    Sci Rep; 2024 Jun; 14(1):13368. PubMed ID: 38862569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olfactory dysfunction as an early predictor for post-COVID condition at 1-year follow-up.
    Granvik C; Andersson S; Andersson L; Brorsson C; Forsell M; Ahlm C; Normark J; Edin A
    Brain Behav; 2024 Jun; 14(6):e3574. PubMed ID: 38841730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers".
    Graham EL; Clark JR; Orban ZS; Lim PH; Szymanski AL; Taylor C; DiBiase RM; Jia DT; Balabanov R; Ho SU; Batra A; Liotta EM; Koralnik IJ
    Ann Clin Transl Neurol; 2021 May; 8(5):1073-1085. PubMed ID: 33755344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving trends in neuropsychological profiles of post COVID-19 condition: A 1-year follow-up in individuals with cognitive complaints.
    Grunden N; Calabria M; García-Sánchez C; Pons C; Arroyo JA; Gómez-Ansón B; Estévez-García MDC; Belvís R; Morollón N; Cordero-Carcedo M; Mur I; Pomar V; Domingo P
    PLoS One; 2024; 19(8):e0302415. PubMed ID: 39116061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychologic Profiles and Cerebral Glucose Metabolism in Neurocognitive Long COVID Syndrome.
    Dressing A; Bormann T; Blazhenets G; Schroeter N; Walter LI; Thurow J; August D; Hilger H; Stete K; Gerstacker K; Arndt S; Rau A; Urbach H; Rieg S; Wagner D; Weiller C; Meyer PT; Hosp JA
    J Nucl Med; 2022 Jul; 63(7):1058-1063. PubMed ID: 34649946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms.
    Calabria M; García-Sánchez C; Grunden N; Pons C; Arroyo JA; Gómez-Anson B; Estévez García MDC; Belvís R; Morollón N; Vera Igual J; Mur I; Pomar V; Domingo P
    J Neurol; 2022 Aug; 269(8):3990-3999. PubMed ID: 35488918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What do we mean by long COVID? A scoping review of the cognitive sequelae of SARS-CoV-2 infection.
    Nicotra A; Masserini F; Calcaterra F; Di Vito C; Doneddu PE; Pomati S; Nobile-Orazio E; Riva A; Mavilio D; Pantoni L
    Eur J Neurol; 2023 Dec; 30(12):3968-3978. PubMed ID: 37540896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of severe COVID-19: spotlight on fatigue, fatigability, multidomain complaints and pattern of cognitive deficits in a case series without prior brain dysfunction and without COVID-19-related stroke and/or cardiac arrest.
    Beaud V; Crottaz-Herbette S; Dunet V; Knebel JF; Bart PA; Clarke S
    J Med Case Rep; 2024 Feb; 18(1):64. PubMed ID: 38303088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological, Medical, and Psychiatric Findings After Recovery From Acute COVID-19: A Cross-sectional Study.
    Ferrando SJ; Dornbush R; Lynch S; Shahar S; Klepacz L; Karmen CL; Chen D; Lobo SA; Lerman D
    J Acad Consult Liaison Psychiatry; 2022; 63(5):474-484. PubMed ID: 35085824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognition and psychological well-being in adults with post COVID-19 condition and analyses of symptom sequelae.
    Ashton Rennison VL; Chovaz CJ; Zirul S
    Clin Neuropsychol; 2024 Feb; 38(2):326-353. PubMed ID: 37350239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring cognitive and psychological alterations in COVID-19 patients: A longitudinal neuropsychological study.
    Diana L; Regazzoni R; Sozzi M; Piconi S; Borghesi L; Lazzaroni E; Basilico P; Aliprandi A; Bolognini N; Bonardi DR; Colombo D; Salmaggi A
    J Neurol Sci; 2023 Jan; 444():120511. PubMed ID: 36473347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for brain fog: Is the montreal cognitive assessment an effective screening tool for neurocognitive complaints post-COVID-19?
    Lynch S; Ferrando SJ; Dornbush R; Shahar S; Smiley A; Klepacz L
    Gen Hosp Psychiatry; 2022; 78():80-86. PubMed ID: 35930974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive screening in patients following SARS-CoV-2 infection: tools for triage.
    Blackmon K; Day GS; Powers HR; Bosch W; Prabhakaran D; Woolston D; Pedraza O
    BMC Neurol; 2022 Jul; 22(1):285. PubMed ID: 35907815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive dysfunction associated with COVID-19: A comprehensive neuropsychological study.
    Delgado-Alonso C; Valles-Salgado M; Delgado-Álvarez A; Yus M; Gómez-Ruiz N; Jorquera M; Polidura C; Gil MJ; Marcos A; Matías-Guiu J; Matías-Guiu JA
    J Psychiatr Res; 2022 Jun; 150():40-46. PubMed ID: 35349797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 severity is related to poor executive function in people with post-COVID conditions.
    Ariza M; Cano N; Segura B; Adan A; Bargalló N; Caldú X; Campabadal A; Jurado MA; Mataró M; Pueyo R; Sala-Llonch R; Barrué C; Bejar J; Cortés CU; ; Garolera M; Junqué C
    J Neurol; 2023 May; 270(5):2392-2408. PubMed ID: 36939932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychiatric and Cognitive Subtypes among Community-Dwelling Older Persons and the Association with DSM-5 Mild Neurocognitive Disorder: Latent Class Analysis.
    Liew TM; Yu J; Mahendran R; Ng TP; Kua EH; Feng L
    J Alzheimers Dis; 2018; 62(2):675-686. PubMed ID: 29480192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence and emergence of new neuropsychological deficits following SARS-CoV-2 infection: A follow-up assessment of the Geneva COVID-COG cohort.
    Voruz P; de Alcântara IJ; Nuber-Champier A; Cionca A; Guérin D; Allali G; Benzakour L; Lalive PH; Lövblad KO; Braillard O; Nencha U; Nehme M; Coen M; Serratrice J; Reny JL; Pugin J; Guessous I; Landis BN; Assal F; Péron JA
    J Glob Health; 2024 Mar; 14():05008. PubMed ID: 38452292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.